Report Detail

Request for Sample of this report

Global Biological API Drug Manufacturing Market Insights, Forecast to 2025

RnM3851880
16 December, 2019
Global
151 Pages
QYResearch
Chemical & Material

This report researches the worldwide Biological API Drug Manufacturing market size (value, capacity, production and consumption) in key regions like North America, Europe, China and Japan.
This study categorizes the global Biological API Drug Manufacturing breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The following manufacturers are covered in this report:
Lonza
Boehringer Ingelheim BioXcellence
Celltrion
DSM
Samsung BioLogics
Fujifilm Diosynth Biotechnologies
Cytovance Biologics
AbbVie
Baxter
CEPiA Sanofi
GSK
Pfizer CentreOne
Sandoz
Vetter
Wuxi Biologics

Biological API Drug Manufacturing Breakdown Data by Type
In-House manufacturing
Contract manufacturing

API contract manufacturing dominates the global biological API drug manufacturing market.

Biological API Drug Manufacturing Breakdown Data by Application
Monoclonal Antibody (mAb) Therapies
Vaccines
Insulin Therapies
Interferon Therapies
Other

Biological API Drug Manufacturing Production Breakdown Data by Region
North America
Europe
China
Japan

Biological API Drug Manufacturing Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Biological API Drug Manufacturing capacity, production, value, consumption, status and forecast;
To focus on the key Biological API Drug Manufacturing manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biological API Drug Manufacturing :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.